SF3B1 and myelodysplastic syndrome: The presence of an SF3B1 mutation appears to be an early event in MDS pathogenesis, being linked to a unique gene expression profile, and is associated with a favorable prognosis and a low risk of progression to acute myeloid leukemia (AML) [26].